This clinical trial is aimed to show a procalcitonin-guided treatment algorithm may shorten duration of antibiotic therapy safely and cost-effectively in sepsis patients of Korean ICU.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
62
Patients who will be randomized to arm will receive antibiotics therapy based on procalcitonin measurement on day 1, 3, 5, 7, 9, 11 and 13.
Patients who will be randomized to this arm will receive antibiotic therapy based on conventional practice.
Seoul National University Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Severance Hospital
Seoul, South Korea
Duration of antibiotic treatment
Time frame: up to 28 days
Clinical response to treatment for infection
success vs failure vs relapse after treatment
Time frame: up to 28 days
In ICU mortality
Time frame: up to 28 days
All cause mortality
Time frame: up to 28 days
In hospital mortality
Time frame: up to 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.